Posts
May 22 2023
Microbot Medical Inc. announced the closing of its Registered Direct offering in the amount of $1,400,000. EG&S acted as counsel to the Placement Agent.
May 19 2023
Baudax Bio, Inc. announced the closing of its Public Offering in the amount of $4,000,000. EG&S acted as counsel to the Placement Agent.
May 17 2023
Biodexa Pharmaceuticals PLC announced the closing of its Registered Direct offering in the amount of $3,320,000. EG&S acted as counsel to the Placement Agent.
May 17 2023
SunCar Technology Group Inc., a leading provider of digitalized enterprise automotive after-sales services and online auto insurance intermediation service in China, announced the completion of the previously announced business combination with Goldenbridge Acquisition Limited, a publicly traded special purpose acquisition company. EGS acted as counsel to Maxim Group LLC, the M&A and financial advisor to Goldenbridge.
May 17 2023
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced the pricing of its registered direct offering in the amount of $4,000,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent for the offering.
May 16 2023
Mawson Infrastructure Group, Inc. announced the closing of its Registered Direct offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.
May 16 2023
Steven Nevolis, a member of the Firm, wrote an article for Total Food Service titled: “A Seat at the Table: Unionization Upswing in Food Service and the Need for Training.”
Click here to read the article.
May 15 2023
Smart for Life, Inc. announced the closing of its Registered Direct offering in the amount of $900,000. EG&S acted as counsel to the Placement Agent.